Teens With Cannabis Use Disorder Face Longer Treatment Delays, Study Finds

Treatment Wait Times Climb for Youth Cannabis Patients

Adolescents with cannabis use disorder now wait an average of 28 days longer to begin treatment compared to 2023, the study found. The research tracked treatment-access data from state-licensed adolescent substance-use programs across twelve states, documenting a consistent pattern of delayed care initiation for youth diagnosed with cannabis use disorder.

The delays come as youth cannabis use rates have remained relatively stable in most states. That suggests the bottleneck lies in treatment capacity rather than demand spikes. States with adult-use cannabis markets showed similar delay patterns to prohibition states, according to the data.

Capacity Constraints Drive Access Gaps

The study attributed the delays primarily to insufficient staffing at licensed adolescent treatment facilities and limited insurance reimbursement rates. Facilities reported difficulty recruiting clinicians with adolescent-specific substance-use credentials, a problem made worse by broader behavioral-health workforce shortages.

Insurance reimbursement for adolescent cannabis use disorder treatment lags behind rates for adult programs and for youth opioid-use treatment. This creates financial disincentives for providers to expand youth cannabis services. Medicaid rates for adolescent outpatient cannabis treatment averaged $87 per session across the twelve states studied, compared to $142 per session for medication-assisted treatment for opioid use disorder.

The financial gap means many facilities prioritize other service lines or adult patients, leaving fewer slots for teens seeking cannabis-specific help. For background on youth cannabis treatment frameworks, see the CannIntel topic hub on youth cannabis use disorder.

Public Health Implications and Next Steps

Delayed treatment access during adolescence can worsen long-term outcomes, as the teenage brain remains particularly vulnerable to substance-use patterns that solidify into adulthood. The study's authors recommended three policy interventions: parity in Medicaid reimbursement rates across substance types, targeted workforce-development grants for adolescent-credentialed clinicians, and expanded telehealth options for rural youth.

Several states have already begun piloting telehealth models for adolescent cannabis counseling. Regulatory barriers around parental consent and cross-state licensure remain unresolved, though. The next major dataset on youth treatment access is expected in Q4 2026 from the Substance Abuse and Mental Health Services Administration.

The study didn't address whether legalization status correlated with treatment-seeking rates, a question that remains contested in public-health literature. What's clear: the teens who do seek help are waiting longer to get it.